ChinaDaily Briefs

Daily Brief China: Greatview Aseptic Packaging, Bloks Group, Xinyi Glass Holdings, Cainiao Smart Logistics Network, PDD Holdings, Alibaba Health Information Tec, China Vanke , Jiangxi Rimag Group and more

In today’s briefing:

  • GAPack (468 HK): Shandong Xinjufeng Offer Progesses
  • Bloks Group Pre-IPO Tearsheet
  • Xinyi Glass (868): Beneficiary of Chinese RE Rejuvenation
  • CaiNiao Q4FY Results: After IPO Withdrawn, Margins Fell | Retention Payments, or Something Else?
  • PDD Holdings: Will The Focus On Agricultural Strategy Convert Into Positive Revenue Growth? – Major Drivers
  • Baba’s Babies: They’re All Grown Up!: Alibaba Health (241 HK) Temperature’s Rising!
  • China Vanke – ESG Report – Lucror Analytics
  • Jiangxi Rimag IPO (2522.HK): Global Offering and Valuation Update


GAPack (468 HK): Shandong Xinjufeng Offer Progesses

By David Blennerhassett

  • On the 9th May, Shandong Xinjufeng (301296 CH) (XJF) made a pre-conditional voluntary general Offer at $2.65/share (best & final), contingent on a 50% acceptance. Final/special dividends to be added.
  • GAPack(468 HK) has made it clear that XJF is a competitor of GAPack. And Mengniu (2319 HK) may review its relationship if pre-cons are satisfied/waived; or the Offer gets up.
  • XJF has announced the necessary applications have been sent to NDRC, MoC, and SAMR; and it prepping for a shareholder meeting to approve the Offer. 

Bloks Group Pre-IPO Tearsheet

By Clarence Chu

  • Bloks Group (1850960D CH) is looking to raise US$300m in its upcoming Hong Kong IPO. The bookrunners on the deal are Goldman Sachs, and Huatai International.
  • Bloks Groups (Bloks) operates in the toy segment where it primarily assembles character toys. Its portfolio contains both self-developed and renowned licensed intellectual property (IPs).
  • According to F&S, Bloks was China’s largest player in the assembly character toy segment with an approximate gross merchandise value (GMV) of RMB1.8bn in 2023.

Xinyi Glass (868): Beneficiary of Chinese RE Rejuvenation

By Henry Soediarko

  • The majority of its revenue comes from selling float glass, which is used in buildings and construction. 
  • The Chinese government has started home ownership relaxation that will reinvigorate the real estate market. 
  • It is still trading at 67% lower to 3 years ago. 

CaiNiao Q4FY Results: After IPO Withdrawn, Margins Fell | Retention Payments, or Something Else?

By Daniel Hellberg

  • After CaiNiao halted IPO in late March, company reported lower Q4 margins
  • What drove Q4 margin deterioration, retention payments or weaker X-border?
  • With IPO off the table, supporting AliExpress becomes CaiNiao’s main role

PDD Holdings: Will The Focus On Agricultural Strategy Convert Into Positive Revenue Growth? – Major Drivers

By Baptista Research

  • PDD Holdings Inc., an innovative online retail company based in China, seems to show a strong future trajectory based on its first quarter 2024 earnings conference call.
  • The company surpassed its year-on-year growth with total revenue reaching RMB 86.8 billion, marking a 131% increase.
  • This impressive growth serves as a testament to PDD Holdings’s efforts to deepen its access and widely influence the consumer market.

Baba’s Babies: They’re All Grown Up!: Alibaba Health (241 HK) Temperature’s Rising!

By David Mudd

  • Alibaba Health Information Tec (241 HK) operates an online platform for healthcare services and products.  Post COVID the company has maintained and grown it the online healthcare market.
  • The company which is 53%-owned by Alibaba Group Holding (9988 HK) , recently reported results for 2023 which beat analyst estimates, recording a 65% increase in net profit.
  • The company recently bought AJK Technology from Taobao which gives Ali Health  operational rights for advertising of online healthcare merchants on Tmall (Alimama).

China Vanke – ESG Report – Lucror Analytics

By Leonard Law, CFA

Lucror Analytics’ ESG Scores are based on a 3-tiered scale and are adjusted for Controversies (if applicable).
We assess China Vanke’s ESG as “Adequate”. The company has “Adequate” scores for all three pillars. Controversies are “Immaterial” and Disclosure is “Strong”.


Jiangxi Rimag IPO (2522.HK): Global Offering and Valuation Update

By Andrei Zakharov

  • Jiangxi Rimag Group, a China-based medical imaging center operator and provider of Rimag cloud services, set terms for an IPO and plans to raise ~HK$280M (~$36M) in Hong Kong.
  • The IPO is expected to be between HK$14.60 and HK$16.80. At the midpoint of the range, Jiangxi Rimag will have a market value of ~HK$5.6B based on 356.3M outstanding shares.
  • CITIC Securities is leading the offering. CMB International and Huatai International act as joint global coordinators, joint bookrunners and joint lead managers.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars